Peter A. McSweeney, MD | Authors


Administering CAR T-Cell Therapy in the Community Setting

October 17, 2022

Peter A. McSweeney, MD, discusses the challenges that come with administering chimeric antigen receptor T-cell therapy. He also explains how CAR T cells entering the second-line may change the ways community practices choose treatments for their patients.